Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFDA approves Tekturna HCT as initial treatment in patients unlikely to achieve their blood pressure goal with a single agent
Novartis, 07/22/09
The US Food and Drug Administration (FDA) has approved Tekturna HCT (aliskiren and hydrochlorothiazide) tablets as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals.
Related Articles
Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Relevance Score: 89%
A brave new beef: The US food and drug administrations review of the safety of cloned animal products
Gender Medicine, 10/26/09
Relevance Score: 89%
FDA Steps Up Efforts to Find, Remove Violators of Clinical Trial Regulations
JAMA, 10/28/09
Relevance Score: 87%
Angiotech Pharmaceuticals Provides Update on Bio-Seal™ 510(K) Submission
Angiotech Pharmaceuticals, 10/20/09
Relevance Score: 87%
The FDA Reviews Safety of Stimulant Medication for ADHD
American Journal of Nursing, 10/01/09
Relevance Score: 87%
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor